XTX Topco Ltd Invests $186,000 in Lifevantage Corporation (NASDAQ:LFVN)

XTX Topco Ltd acquired a new position in shares of Lifevantage Corporation (NASDAQ:LFVN) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 12,749 shares of the company’s stock, valued at approximately $186,000. XTX Topco Ltd owned 0.10% of Lifevantage at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Capital Management Corp VA lifted its position in Lifevantage by 137.2% during the 1st quarter. Capital Management Corp VA now owns 715,503 shares of the company’s stock worth $10,432,000 after acquiring an additional 413,918 shares during the last quarter. Brown Advisory Inc. bought a new position in shares of Lifevantage in the first quarter worth about $150,000. Calamos Advisors LLC bought a new position in shares of Lifevantage in the first quarter worth about $490,000. Cannon Global Investment Management LLC acquired a new position in shares of Lifevantage during the 1st quarter worth about $156,000. Finally, Cambridge Investment Research Advisors Inc. boosted its stake in Lifevantage by 23.2% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company’s stock valued at $188,000 after purchasing an additional 2,421 shares during the period. 35.32% of the stock is currently owned by institutional investors and hedge funds.

Lifevantage Stock Up 2.5%

LFVN opened at $14.51 on Thursday. The stock’s 50 day moving average price is $12.94 and its two-hundred day moving average price is $14.54. The firm has a market capitalization of $182.68 million, a P/E ratio of 21.03 and a beta of 0.45. Lifevantage Corporation has a 12-month low of $7.09 and a 12-month high of $27.38.

Insider Buying and Selling at Lifevantage

In related news, CFO Carl Aure sold 2,746 shares of the business’s stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $13.39, for a total transaction of $36,768.94. Following the transaction, the chief financial officer owned 133,303 shares of the company’s stock, valued at approximately $1,784,927.17. The trade was a 2.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 20.65% of the company’s stock.

About Lifevantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.